Sun Pharmaceutical recalling over 1.10 lakh bottles of generic medication in US market
22nd Nov 2021

Sun Pharmaceutical Industries is recalling over 1.10 lakh bottles of a generic medication used to treat erectile dysfunction in men in the US market due to a manufacturing error. The US arm of the domestic pharma major is recalling Tadalafil tablets in the American market, according to the latest enforcement report of the US Food and Drug Administration (USFDA). The company is recalling the product in 30-count bottles of 5mg and 20 mg strengths.

The company is recalling 73,957 bottles of 5 mg strength and 36,786 bottles of 20 mg strength. An affected lot of the medication was manufactured by the drug maker in India and distributed in the US by Princeton, New Jersey-based Sun Pharmaceutical Industries Inc.

Sun Pharma is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.